v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 3,515 $ 4,894
Research and development supplies and other current assets 1,807 0
Prepaid expenses 528 1,455
Total current assets 5,850 6,349
Property and equipment, net 710 842
Operating lease right-of-use asset, net 1,321 2,380
Other assets 48 48
Total assets 7,929 9,619
Current liabilities    
Accounts payable and accrued expenses 1,821 945
Operating lease liability, short-term 258 706
Loan payable 124 0
SEPA put option liability 10 108
Total current liabilities 2,213 1,759
Operating lease liability, long-term 1,080 1,704
Total liabilities 3,293 3,463
Stockholders’ equity    
Preferred Stock, value 0 0
Voting Common Stock, $0.00001 par value; 300,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 6,080,560 shares and 3,325,986 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 1 1
Additional paid-in capital 67,916 60,319
Accumulated deficit (63,281) (54,164)
Total stockholders’ equity 4,636 6,156
Total liabilities and stockholders’ equity 7,929 9,619
Series C Preferred Stock [Member]    
Stockholders’ equity    
Preferred Stock, value $ 0 $ 0